Acrivon Therapeutics Ownership | Who Owns Acrivon Therapeutics?
Acrivon Therapeutics Ownership Summary
Acrivon Therapeutics is owned by 2.79% institutional investors, 20.57% insiders, and 76.64% retail investors. Ra capital management is the largest institutional shareholder, holding 21.69% of ACRV shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.73% of its assets in Acrivon Therapeutics shares.
ACRV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Acrivon Therapeutics | 2.79% | 20.57% | 76.64% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 8.34M | 21.69% | $15.10M |
| Sands capital ventures | 2.12M | 5.52% | $3.84M |
| Wellington management group llp | 888.13K | 2.31% | $1.61M |
| Vanguard group | 698.86K | 1.81% | $1.68M |
| Renaissance | 634.17K | 1.64% | $1.53M |
| Acadian asset management | 581.21K | 1.51% | $1.40M |
| Acorn capital advisors | 405.24K | 1.05% | $733.48K |
| Ubs group | 348.54K | 0.90% | $839.98K |
| Jane street group | 342.07K | 0.89% | $824.39K |
| Two sigma investments, lp | 319.20K | 0.83% | $577.76K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sands capital ventures | 2.12M | 0.84% | $3.84M |
| Acorn capital advisors | 405.24K | 0.37% | $733.48K |
| Ra capital management | 8.34M | 0.19% | $15.10M |
| Aaf wealth management | 10.68K | 0.01% | $25.73K |
| Xtx topco | 35.95K | 0.00% | $65.08K |
| Renaissance | 634.17K | 0.00% | $1.53M |
| Acadian asset management | 581.21K | 0.00% | $1.40M |
| Algert global | 44.65K | 0.00% | $81.00K |
| Two sigma investments, lp | 319.20K | 0.00% | $577.76K |
| Bridgeway capital management | 22.90K | 0.00% | $41.45K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Acadian asset management | 581.21K | 0.00% | 489.20K |
| Two sigma investments, lp | 319.20K | 0.00% | 138.03K |
| Two sigma advisers, lp | 136.50K | 0.00% | 103.90K |
| Goldman sachs group | 119.42K | - | 99.68K |
| Vanguard group | 698.86K | - | 72.71K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | - | - | -5.36M |
| Ubs group | 348.54K | 0.00% | -334.68K |
| Hrt financial lp | - | - | -145.90K |
| Blackrock funding, inc. /de | 205.12K | - | -125.83K |
| Dafna capital management | - | - | -112.41K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Algert global | 44.65K | 0.00% | 44.65K | $81.00K |
| Marex group | 10.00K | 0.00% | 10.00K | $24.10K |
| Optima capital | 278.00 | 0.00% | 278.00 | $670.00 |
Sold Out
| Holder | Change |
|---|---|
| Wells fargo & company/mn | -141.00 |
| True wealth design | -176.00 |
| Sterling capital management | -198.00 |
| Gamma investing | -287.00 |
| Amalgamated bank | -378.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | -84.78% | 1,075,876 | -93.85% | 2 | 0.14% | 3 | -81.25% | 1 | -94.44% |
| Sep 30, 2025 | 10 | -80.77% | 655,031 | -96.32% | 1 | 0.08% | 5 | -80.77% | 3 | -81.25% |
| Jun 30, 2025 | 51 | -15.00% | 17,796,335 | -20.97% | 46 | 1.34% | 25 | 4.17% | 16 | -23.81% |
| Mar 31, 2025 | 4 | -93.10% | 14,129,412 | -38.60% | 36 | 1.01% | - | -100.00% | 1 | -92.86% |
| Dec 31, 2024 | 59 | 15.69% | 23,249,551 | 1.26% | 61 | 1.68% | 31 | 29.17% | 14 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 545.54K | 1.73% | 131.90K |
| HBM Healthcare Investments AG Ord | 527.15K | 1.68% | -39.51K |
| Vanguard US Total Market Shares ETF | 387.41K | 1.24% | - |
| Lago Erie SICAV | 194.44K | 0.62% | 194.44K |
| Vanguard Institutional Extnd Mkt Idx Tr | 161.39K | 0.51% | 7.31K |
| Fidelity Small Cap Index | 129.48K | 0.41% | - |
| iShares Biotechnology ETF | 125.85K | 0.40% | - |
| iShares Russell 2000 Value ETF | 108.94K | 0.35% | - |
| Fidelity Extended Market Index | 102.36K | 0.32% | 2.55K |
| A4Investments SICAV SIF ACCI IlanaA2EURH | 84.78K | 0.27% | 30.72K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 14, 2026 | Blume-Jensen Peter | President and CEO | Buy | $82.12K |
| Jan 14, 2026 | Levy Adam D. | Chief Financial Officer | Buy | $15.00K |
| Jan 13, 2026 | Devroe Eric | Chief Operating Officer | Buy | $17.22K |
| Apr 30, 2025 | PERCEPTIVE ADVISORS LLC | - | Sell | $617.41K |
| May 01, 2025 | PERCEPTIVE ADVISORS LLC | - | Sell | $400.51K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 3 | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 5 |
| 2025 Q1 | - | - |
ACRV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools